Cargando…
P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430685/ http://dx.doi.org/10.1097/01.HS9.0000848708.67906.8b |
| _version_ | 1784779842515894272 |
|---|---|
| author | Broijl, A. van de Donk, N. Bosch, F. Mateos, M. V. Rodriguez-Otero, P. Tucci, A. Ghia, P. Adang, A. Parren, P. Tuinhof, I. Umarale, S. Winograd, B. van der Vliet, H. Kater, A. |
| author_facet | Broijl, A. van de Donk, N. Bosch, F. Mateos, M. V. Rodriguez-Otero, P. Tucci, A. Ghia, P. Adang, A. Parren, P. Tuinhof, I. Umarale, S. Winograd, B. van der Vliet, H. Kater, A. |
| author_sort | Broijl, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430685 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94306852022-08-31 P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES Broijl, A. van de Donk, N. Bosch, F. Mateos, M. V. Rodriguez-Otero, P. Tucci, A. Ghia, P. Adang, A. Parren, P. Tuinhof, I. Umarale, S. Winograd, B. van der Vliet, H. Kater, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430685/ http://dx.doi.org/10.1097/01.HS9.0000848708.67906.8b Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Broijl, A. van de Donk, N. Bosch, F. Mateos, M. V. Rodriguez-Otero, P. Tucci, A. Ghia, P. Adang, A. Parren, P. Tuinhof, I. Umarale, S. Winograd, B. van der Vliet, H. Kater, A. P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES |
| title | P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES |
| title_full | P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES |
| title_fullStr | P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES |
| title_full_unstemmed | P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES |
| title_short | P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECIFIC GAMMA-DELTA T-CELL ENGAGER (GAMMABODY™), IN RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES |
| title_sort | p1463: phase i dose escalation of lava-051, a novel bispecific gamma-delta t-cell engager (gammabody™), in relapsed/refractory hematological malignancies |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430685/ http://dx.doi.org/10.1097/01.HS9.0000848708.67906.8b |
| work_keys_str_mv | AT broijla p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT vandedonkn p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT boschf p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT mateosmv p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT rodriguezoterop p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT tuccia p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT ghiap p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT adanga p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT parrenp p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT tuinhofi p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT umarales p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT winogradb p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT vandervlieth p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies AT katera p1463phaseidoseescalationoflava051anovelbispecificgammadeltatcellengagergammabodyinrelapsedrefractoryhematologicalmalignancies |